Skip to content
Search

Latest Stories

Patient safety more critical than ever, says former LloydsPharmacy Superintendent

Victoria says that automation can help reduce patient safety incidents significantly when properly managed.
Victoria Steele

Victoria Steele shares insights from her recent experience at LP Healthcare Services and her role as chair of the Community Pharmacy Patient Safety Group

With community pharmacies taking on more clinical services, patient safety remains a significant concern, says Victoria Steele, former superintendent of LloydsPharmacy (McKesson UK).

A huge patient safety advocate, Victoria was one of the founding members in 2015 and chair or vice-chair of the UK’s Community Pharmacy Patient Safety Group until 2023.


“Community pharmacy is progressing rapidly and is being asked to do more and more, which is what we should be doing. But with the advent of Pharmacy First, vaccination services, and the increasing number of independent prescribers, there comes an inherent risk that we all need to learn quickly from new services and manage the inevitable new risks.”

“At the moment, my biggest worry is how we’re learning quickly when things go wrong in these new services,” she tells Pharmacy Business. 

While she is confident that individual pharmacies and Local Pharmacy Committees (LPCs) are working on improvements, she remains concerned about how data from patient safety incidents is being collected, learnt from and these learnings shared.

She stresses the need for faster, more effective learning and response mechanisms.

Victoria calls for more efficient collaboration and data-sharing platforms, like the Patient Safety Group, which could support the sector by feeding in valuable insights and resources.

Victoria was leading the patient safety agenda at LP Healthcare Services, before she stepped down as the group’s Clinical Director in July this year.

She played a key role in implementing the award winning and industry leading SaferCare patient safety programme which transformed standards of patient and professional care across the entirety of LloydsPharmacy and LP healthcare services, reducing patient safety incidents dramatically.

Victoria says that automation can help reduce patient safety incidents significantly when properly managed.

She emphasises the importance of taking a cautious approach when introducing automation, such as hub-and-spoke and robotic systems, noting that “a glitch in the data transfer has the potential to impact tens of thousands of patients.”

Reason for leaving Lloyds

After serving over 13 years at lloydsPharmacy and LP Healthcare Services, Victoria left the group in July this year to take a career break, which she says was very much needed having not stopped working since graduating 25 years ago.

Victoria says that taking the summer off allowed her time to reflect and consider her next steps, and she now feels ready to move forward in her career.

Becoming the Superintendent of LloydsPharmacy  and chairing the UK's Community Pharmacy Patient Safety Group were her two big career goals —both of which she achieved in 2020 and 2021.

She served as Superintendent for LloydsPharmacy (McKesson UK) from December 2020 to November 2023. Prior to this, she was Head of Clinical Governance and Professional Standards at Celesio UK following the 2012 merger of LloydsPharmacy and AAH Pharmaceuticals.

Professional isolation in community pharmacy

Victoria found working in LP healthcare services fulfilling and decidedly different to working in community pharmacy.

She explains: “There is a real risk of professional isolation in community pharmacy, where individual pharmacists often work alone with limited opportunities for clinical discussions.”

“In healthcare services, particularly in outpatient dispensing units, pharmacists typically worked alongside other professionals, allowing for easy collaboration. This ability to discuss clinical problems easily is fantastic and, from a job satisfaction point of view, very rewarding.”

She also enjoyed working in healthcare services because it provides the opportunity for many more direct patient interactions, where pharmacists routinely engage with patients, providing counseling and checking on their mental health and well-being.

“This level of patient care is more challenging to achieve in a busy high street community pharmacy,” she adds.

Championing women in pharmacy

For Victoria, one of the proudest parts of being the superintendent of Lloyds pharmacy was her ability to support female pharmacists and up and coming pharmacists.

“I was incredibly flattered when, in the summer after I left, numerous young women reached out to tell me how I had helped them through challenging chapters in their lives.”

She feels that women find it more difficult to climb the career ladder due to family responsibilities, which still disproportionately fall on them.

She also highlights the gender pay gap as a significant issue, observing that in many private organisations, women are still paid less than their male counterparts.

For women who are hesitant to apply for higher roles, Victoria advises: “Believe in yourself and put yourself out there because opportunities don't usually come knocking on your door. You've got to go and find them, and you have to let people know that you can do the job.”

Victoria is involved with several charities and is a founding member of the Bowel Cancer UK Development and Appeal Boards that fund research aimed at reducing deaths from the disease.

Future of community pharmacy

Victoria envisions a collaborative model for local pharmacies, where patients could visit different pharmacy locations for specialized services, such as vaccinations or consultations with an independent prescriber for menopause (amongst many other things).

“This approach would be similar to how GP practices operate, where patients visit different surgeries for services like COVID vaccinations or physiotherapy.”

Although she acknowledges the challenges due to the independent nature of many pharmacy businesses, she believes this model could offer a powerful way to enhance pharmacy services by working together.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less